Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events

Abstract The application of immune checkpoint inhibitors (ICIs) has rewritten many malignant tumor treatment strategies and become another milestone in tumor treatment. This article summarizes the latest domestic and international guidelines and consensus regarding the diagnosis and treatment of gra...

Full description

Bibliographic Details
Main Authors: Peng Song, Hanping Wang, Xiaoyan Si, Xiaoxiao Guo, Yue Li, Jiaixin Zhou, Lian Duan, Li Zhang, Mengzhao Wang
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Thoracic Cancer
Subjects:
Adverse events
critical
refractory
immune checkpoint inhibitor
Online Access:https://doi.org/10.1111/1759-7714.13553

Internet

https://doi.org/10.1111/1759-7714.13553

Similar Items